Skip to content
Open access · CC-BY via OpenAlex

Intermittent Fasting and Fat Mass: What Is the Clinical Magnitude?

Heitor Oliveira Santos

Obesities · 2022 · ▲ 17 citations

Abstract

Clinical studies addressing the benefits of intermittent fasting (IF) diets have evoked interest in the treatment of obesity. Herein, the overall effects of IF regimens on fat-mass loss are explained in a brief review through a recent literature update. To date, human studies show a reduction in fat mass from 0.7 to 11.3 kg after IF regimens, in which the duration of interventions ranges from two weeks to one year. In light of this, IF regimens can be considered a reasonable approach to weight (fat mass) loss. However, the benefits of IF regimens occur thanks to energy restriction and cannot hence be considered the best dietary protocol compared to conventional diets.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3390/obesities2010001
Canonical
link ↗
Fetched
2026-10-10 MST

Cite this

APA
Santos, H.O. (2022). Intermittent Fasting and Fat Mass: What Is the Clinical Magnitude?. <em>Obesities</em>. https://doi.org/10.3390/obesities2010001
Vancouver
Santos HO. Intermittent Fasting and Fat Mass: What Is the Clinical Magnitude?. Obesities. 2022. doi:10.3390/obesities2010001.
BibTeX
@article{heitor2022Interm, title = {Intermittent Fasting and Fat Mass: What Is the Clinical Magnitude?}, author = {Heitor Oliveira Santos}, journal = {Obesities}, year = {2022}, doi = {10.3390/obesities2010001}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings